CA2349711A1 - A method of producing drug particles - Google Patents

A method of producing drug particles Download PDF

Info

Publication number
CA2349711A1
CA2349711A1 CA002349711A CA2349711A CA2349711A1 CA 2349711 A1 CA2349711 A1 CA 2349711A1 CA 002349711 A CA002349711 A CA 002349711A CA 2349711 A CA2349711 A CA 2349711A CA 2349711 A1 CA2349711 A1 CA 2349711A1
Authority
CA
Canada
Prior art keywords
drug particles
producing drug
producing
susceptible
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002349711A
Other languages
French (fr)
Other versions
CA2349711C (en
Inventor
Catherine Boissier
Anne Mari Juppo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astrazeneca Ab
Catherine Boissier
Anne Mari Juppo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Catherine Boissier, Anne Mari Juppo filed Critical Astrazeneca Ab
Publication of CA2349711A1 publication Critical patent/CA2349711A1/en
Application granted granted Critical
Publication of CA2349711C publication Critical patent/CA2349711C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions

Abstract

A method of preparing drug particles of a substance which are susceptible to degradation by the use of a fluid gas technique.
CA002349711A 1998-11-23 1999-11-22 A method of producing drug particles Expired - Fee Related CA2349711C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (en) 1998-11-23 1998-11-23 A method of producing drug particles
SE9804003-3 1998-11-23
PCT/SE1999/002152 WO2000030612A1 (en) 1998-11-23 1999-11-22 A method of producing drug particles

Publications (2)

Publication Number Publication Date
CA2349711A1 true CA2349711A1 (en) 2000-06-02
CA2349711C CA2349711C (en) 2008-07-15

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002349711A Expired - Fee Related CA2349711C (en) 1998-11-23 1999-11-22 A method of producing drug particles

Country Status (12)

Country Link
US (1) US6596315B1 (en)
EP (1) EP1133283B1 (en)
JP (1) JP4612191B2 (en)
AT (1) ATE278390T1 (en)
AU (1) AU754385B2 (en)
CA (1) CA2349711C (en)
DE (1) DE69920945T2 (en)
DK (1) DK1133283T3 (en)
ES (1) ES2228148T3 (en)
PT (1) PT1133283E (en)
SE (1) SE9804003D0 (en)
WO (1) WO2000030612A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
AU2003217691A1 (en) 2002-02-25 2003-09-09 Phasex Corporation Method for drying water-borne materials
EP1499296B1 (en) 2002-04-15 2012-04-04 MAP Pharmaceuticals Inc Formulation of fine particles using liquefied or dense gases
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
AU2004237131B2 (en) 2003-05-08 2009-09-10 Nektar Therapeutics Particulate materials
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2006272438B2 (en) 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
HUE026884T2 (en) 2007-02-11 2016-08-29 Map Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (en) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh METHOD FOR THE PRODUCTION OF AT LEAST ONE ACTIVE AGENT AND A TRAITER COMPRISING PREPARATION
JP2843857B2 (en) * 1988-10-05 1999-01-06 ファルマシア・アンド・アップジョン・カンパニー Finely divided solid crystalline powder via precipitation in antisolvent
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
MX9704550A (en) 1994-12-22 1997-10-31 Astra Ab Aerosol drug formulations.
EP0855906B1 (en) * 1995-10-17 2008-02-20 Jagotec AG Insoluble drug delivery
SE510666C2 (en) 1996-12-20 1999-06-14 Astra Ab New Crystal Modifications

Also Published As

Publication number Publication date
DK1133283T3 (en) 2005-01-24
DE69920945T2 (en) 2005-08-25
EP1133283B1 (en) 2004-10-06
ATE278390T1 (en) 2004-10-15
SE9804003D0 (en) 1998-11-23
PT1133283E (en) 2005-01-31
DE69920945D1 (en) 2004-11-11
WO2000030612A1 (en) 2000-06-02
CA2349711C (en) 2008-07-15
AU2010200A (en) 2000-06-13
ES2228148T3 (en) 2005-04-01
AU754385B2 (en) 2002-11-14
EP1133283A1 (en) 2001-09-19
JP2002530317A (en) 2002-09-17
US6596315B1 (en) 2003-07-22
JP4612191B2 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
CA2349711A1 (en) A method of producing drug particles
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
HK1033816A1 (en) A process for the manufacturing of a decorative laminate, a decorative laminate obtained by the process and use thereof
HUP0102921A3 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
WO2001010816A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
AU7447896A (en) Processes for the preparation of octafluoro-{2,2}paracyclophane
AU6830900A (en) Method for the production of three-dimensional or flat structures
AU3355595A (en) Photocatalyst, method for preparing the same, and production of hydrogen using the same
AU4278897A (en) 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds
AU1540995A (en) Methods for the production of modified plants
HUP9602640A3 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
AU5160599A (en) Method for the production of n,n'-carbonyl diazoles
GB2343892B (en) Process for the preparation of d,l-menthol
ZA963132B (en) Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine.
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU3343899A (en) 2-anilinopyrimidinone derivatives, intermediates in the production thereof, process for producing the same and pesticides containing the same as the active ingredient
AU3012101A (en) Method for the production of polyamides
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
AU7017398A (en) Plant for manufacturing gas by electrolysis
EP0739896A3 (en) Process for the preparation of 6-oxo-(6H)-dibenz-(c,e)(1,2)-oxaphosphorines
CA2292017A1 (en) Substituted cycloheptenes, their preparation and use
AU4758400A (en) Method for the production of polyamides
AU5286499A (en) Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments
AU3139999A (en) Method for the production of 1,3-disubstituted 2-nitroguanidines

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131122